Genius Sports Limited
NYSE:GENIInternet Content & Information
-$0.05 today
- Market cap
- $1.64B
- Beta
- 1.92
- P/E (TTM)
- -10.4
- EPS (TTM)
- -$0.59
Volume 7.36M
Average 6.05M
GENI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Genius Sports LimitedNYSE: GENI
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $11.4M rose 27.5% year over year, ahead of the +24.7% change in trailing-twelve-month research & development. Sequentially, it rose 34.6% from the prior quarter. Over 3 fiscal years it compounded at +1.3% a year.
Context
- Research & development amounted to 4.6% of revenue in FY2025, down 0.2 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +27.5% holds above the trailing-twelve-month pace of +24.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 31.09M USD
- Year-over-year change
- +26.5%
- 4-year CAGR
- +4.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 31.09M | +26.5% |
| FY2024 | 2024-12-31 | 24.58M | -5.7% |
| FY2023 | 2023-12-31 | 26.07M | -12.8% |
| FY2022 | 2022-12-31 | 29.89M | +12.8% |
| FY2021 | 2021-12-31 | 26.51M | — |
Research & Development vs competitors
How GENI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +24.7% is the 2nd highest of 8, against a peer median of -7.9%.
- Research & development amounts to 4.7% of revenue for GENI, versus a peer median of 9.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $322.2M USD | +6.0% | -7.8% | 18.1% | |
| LTM Mar 2026 | $306.94M USD | -3.7% | +0.9% | 20.9% | |
| LTM Jun 2026 | $238.93M USD | -8.9% | -1.9% | 10.5% | |
| LTM Jun 2026 | $164.3M USD | -29.9% | -22.2% | 7.9% | |
| LTM Mar 2026 | CN¥115.33M CNY | -28.0% | -31.9% | 3.1% | |
| LTM Jun 2026 | $33.78M USD | -7.9% | +46.4% | 747.4% | |
| LTM Mar 2026 | $33.54M USD | +24.7% | +1.3% | 4.7% | |
| LTM Jun 2026 | $21.49M USD | +31.7% | +3.6% | 540.5% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | £0 GBP | — | — | 0.0% | |
KYIVKyivstar Group Ltd. Common Shares | LTM Jun 2026 | $0 USD | — | — | 0.0% |
| Peer median (excluding GENI) | — | -7.9% | -1.9% | 9.2% | |
Competitors are the stored peer set for GENI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 262.74M | 341.03M | 412.98M | 510.89M | 669.49M |
| Cost of Revenue | 476.17M | 338.17M | 343.97M | 382.19M | 515.65M |
| Gross Profit | (213.43M) | 2.86M | 69.01M | 128.71M | 153.84M |
| Gross Margin | -81.2% | 0.8% | 16.7% | 25.2% | 23.0% |
| Research & Development | 26.51M | 29.89M | 26.07M | 24.58M | 31.09M |
| Selling, General & Admin | 320.46M | 154.17M | 114.6M | 160.42M | 264.13M |
| Operating Expenses | 359.86M | 185.74M | 143.16M | 187.24M | 295.22M |
| Depreciation & Amortization | 59.35M | 68.53M | 77.31M | 72.57M | 70.52M |
| EBITDA | (541.77M) | (112.68M) | 5.64M | 16.28M | (43.55M) |
| EBITDA Margin | -206.2% | -33.0% | 1.4% | 3.2% | -6.5% |
| Operating Income | (573.29M) | (182.87M) | (74.16M) | (58.54M) | (141.38M) |
| Operating Margin | -218.2% | -53.6% | -18.0% | -11.5% | -21.1% |
| Interest Income | 0 | 0 | 1.95M | 921K | 0 |
| Interest Expense | 3.33M | 1.49M | 0 | 0 | 6K |
| Other Income / Expenses | (31.16M) | 2.95M | (6.04M) | (3.99M) | 27.3M |
| Income Before Tax | (604.45M) | (179.92M) | (80.19M) | (62.53M) | (114.08M) |
| Pre-Tax Margin | -230.1% | -52.8% | -19.4% | -12.2% | -17.0% |
| Income Tax Expense | (11.7M) | 1.71M | 5.34M | 509K | (2.5M) |
| Net Income | (592.75M) | (181.64M) | (85.53M) | (63.04M) | (111.58M) |
| Net Margin | -225.6% | -53.3% | -20.7% | -12.3% | -16.7% |
| EPS (Basic) | (3.93) | (0.91) | (0.38) | (0.27) | (0.44) |
| EPS (Diluted) | (3.93) | (0.91) | (0.38) | (0.27) | (0.44) |
| Weighted Avg Shares | 150.91M | 198.94M | 225.88M | 229.51M | 254.76M |
| Weighted Avg Shares (Diluted) | 150.91M | 198.94M | 225.88M | 229.51M | 254.76M |
Genius Sports Limited
NYSE:GENI
Intrinsic Alpha fair value
Locked
Current Price
$6.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.